PHILIP MORRIS INTERNATIONAL, INC.
Last · NYSE$199.88-5.705 (-2.78%)live · yahoo · 1h ago
Market cap$311.53B1.56B sh
P/E · TTM27.8fwd 21.8 · eps 7.18
Beta—vs S&P 500
Div yield2.86%annual · TTM
52w range
$142.11$210.44
Volume5.6Msession
| Revenue | $42.5B |
|---|---|
| Operating income | $16.1B |
| Net income | $10.8B |
| Free cash flow | $12.7B |
| Operating margin | 37.7% |
| Net margin | 25.5% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-02-06
- Smoke Free Transition
- Iqos Zyn Growth
- Ktg Partnership
- High Leverage
- Russia Cash Exposure
- Regulatory Tax Risk
- Tobacco Litigation
Red flags
- Total debt increased to $48.8 billion from $45.7 billion in 2024, while 2025 financing cash outflow was $8.1 billion and dividends paid were $8.6 billion.
- $2.3 billion of PMI’s $4.9 billion cash balance was held in Russia at December 31, 2025; capital controls and currency restrictions can limit repatriation and dividend flows.
- Highly inflationary accounting in Argentina, Egypt, Turkey, and Lebanon generated a $26 million exchange loss in 2025, after losses of $46 million in 2024 and $194 million in 2023.
- Management says it cannot estimate the possible loss range for pending tobacco and nicotine litigation, while certain health-care cost recovery claims could reach billions of dollars.
- The company relied more heavily on factoring trade receivables in 2025, while working capital consumed an additional $2.4 billion, raising the quality and timing sensitivity of reported operating cash flow.
Upcoming earnings
2:30 PM UTC+2
Period
Sep 2026
Est. EPS
$2.32
Est. revenue
11.4B
Earnings transcripts
Press & signals
- Satelight
Philip Morris allowed to market Zyn pouches in US as safer than smoking
Documents
FormReporting forFiledFlags